|
|
Pharmaceuticals
| ||||||||||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||||||||
|
Current Pharmaceuticals News Today Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls. These data expand on earlier findings and reveal that a ... Fri, 03 Sep 2010 05:27:11 -0700 Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada... Fri, 03 Sep 2010 05:28:31 -0700 Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 CORK, Ireland, September 3, 2010 /PRNewswire/ -- Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once ... Fri, 03 Sep 2010 08:01:54 -0700 Rexahn Pharmaceuticals publishes research article on RX-8243 anti-tumor activity Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues. Thu, 02 Sep 2010 21:57:22 -0700 Early Glance: Pharmaceuticals companies NEW YORK (AP) -- Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Baxter fell $.04 or .1 percent, to $43.96. Bristol-Myers Squibb fell $.02 or .1 percent, to $26.41. Hospira rose $.62 or 1.1 percent, to $54.68. Johnson & Johnson rose $.20 or .3 percent, to $58.81. King Pharmaceuticals rose $.06 or .6 percent, to $9.23. Eli Lilly rose $.23 or .7 percent, to $34.54. Merck rose ... Fri, 03 Sep 2010 07:46:20 -0700 |
| Copyright 2006-2008 by Sleek Seo Web Directory All Rights Reserved Power : PHPLD |
